Korean J Dermatol.
2008 Jun;46(6):809-811.
A Case of Vitiligo in a Hepatitis C Patient after Pegylated Interferon Treatment
- Affiliations
-
- 1Department of Dermatology, Ajou University School of Medicine, Suwon, Korea. hykang@ajou.ac.kr
Abstract
- The use of pegylated interferon (PEG-IFN) and ribavirin is considered standard therapy for patients with chronic hepatitis C. The treatment has been linked with a number of dermatologic manifestations such as alopecia, skin rash, pruritus, injection site inflammation and occasionally, with vitiligo. We report a case of vitiligo that occurred during treatment with PEG-IFN and ribavirin in a hepatitis C patient. The autoimmune adverse effects of IFN therapy should be considered in the treatment of vitiligo in such patients.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Alopecia Areata in a Patient Treated with Interferon Alpha-2a for Chronic Hepatitis B
- A Case of Cutaneous Sarcoidosis Associated with Pegylated Interferon Alpha-2a and Ribavirin Therapy
- Pegylated Interferon-Associated Severe Retinopathy in a Patient with Chronic Hepatitis
- Pegylated Interferon Associated Retinopathy in Chronic Hepatitis Patients
- Thymosin Alpha-1 in Combination with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients Who have Failed to Prior Pegylated Interferon and Ribavirin Treatment
